Srestha Finvest Valuation
Is 539217 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 539217 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 539217's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 539217's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 539217?
Other financial metrics that can be useful for relative valuation.
What is 539217's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹713.40m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 539217's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.8x | ||
530789 Ceejay Finance | 3.3x | n/a | ₹660.0m |
538714 Sangam Finserv | 7.7x | n/a | ₹1.1b |
509053 Banas Finance | 0.6x | n/a | ₹762.0m |
535267 Comfort Fincap | 3.7x | n/a | ₹514.4m |
539217 Srestha Finvest | 28.1x | n/a | ₹713.4m |
Price-To-Sales vs Peers: 539217 is expensive based on its Price-To-Sales Ratio (28.1x) compared to the peer average (3.8x).
Price to Earnings Ratio vs Industry
How does 539217's PE Ratio compare vs other companies in the IN Diversified Financial Industry?
Price-To-Sales vs Industry: 539217 is expensive based on its Price-To-Sales Ratio (28.1x) compared to the Indian Diversified Financial industry average (8.7x).
Price to Sales Ratio vs Fair Ratio
What is 539217's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 28.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 539217's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.